InflaRx NV
SWB:IF0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InflaRx NV
SWB:IF0
|
DE |
|
Agatos SpA
F:5JS1
|
IT |
|
N
|
NorthWestern Corp
F:NWZA
|
US |
|
C
|
CES Energy Solutions Corp
OTC:CESDF
|
CA |
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
E
|
Evergreen Lithium Ltd
ASX:EG1
|
AU |
|
Delta Drone International Ltd
ASX:DLT
|
AU |
|
F
|
Fattal Holdings 1998 Ltd
TASE:FTAL
|
IL |
|
Desktop Metal Inc
F:844
|
US |
|
E
|
Enerflex Ltd
F:7EX
|
CA |
|
Dom Development SA
F:6WV
|
PL |
|
CES Synergies Inc
OTC:CESX
|
US |
|
Rubicon Organics Inc
F:R07
|
CA |
|
RJD Green Inc
OTC:RJDG
|
US |
|
Bell Equipment Ltd
F:B2K
|
ZA |
|
Cobre Ltd
ASX:CBE
|
AU |
Bankruptcy Probability
InflaRx NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
InflaRx NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
InflaRx NV
NASDAQ:IFRX
|
297.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
InflaRx NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, InflaRx NV has total debt of 608.6k EUR. This includes both short-term (0 EUR) and long-term (608.6k EUR) debt.
You can find a full breakdown on its Balance Sheet.
